COMPOUND PROFILE / SMALL MOLECULES
Metformin.
Research draftMetformin is a small-molecule prescription medicine widely used for type 2 diabetes.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
Metformin is a small-molecule prescription medicine widely used for type 2 diabetes.
Mechanism
It reduces hepatic glucose production through complex metabolic actions; it is not simply a universal AMPK activator.
Human research
Diabetes evidence is extensive. Human lifespan extension in otherwise healthy people is not established.
Preclinical & other research
Animal and cellular ageing findings generate hypotheses, not proven human longevity effects.
Safety & unknowns
Gastrointestinal effects, vitamin B12 changes and lactic-acidosis risk in susceptible settings matter.
Regulatory status
Approved diabetes treatment does not establish an approved anti-ageing indication.
Reported use & evidence
The supplied Metformin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.